TNF Pharmaceuticals, Inc.
NASDAQ: TNFA0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Mitchell Glass
- Employees
- 2
- Headquarters
- New York City, United States
- IPO year
- 2014
- Market cap
- $9.2M
- Website
- https://tnfpharma.com
Loading TNFA…
Loading profile data…Frequently asked questions about TNFA
What does TNF Pharmaceuticals, Inc. (TNFA) do?
TNF Pharmaceuticals, Inc. is a clinical-stage pharmaceutical firm dedicated to developing advanced therapeutic platforms that tackle the root causes of diseases, rather than just managing symptoms. Its flagship drug platform, MYMD-1, is a small molecule currently undergoing clinical trials. This platform functions by modulating the immune system...
Where does TNFA trade?
TNF Pharmaceuticals, Inc. (TNFA) trades on the NASDAQ Global Market.
What sector is TNFA in?
TNF Pharmaceuticals, Inc. (TNFA) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of TNF Pharmaceuticals, Inc.?
Mitchell Glass is the chief executive officer of TNF Pharmaceuticals, Inc. (TNFA).
Where is TNF Pharmaceuticals, Inc. headquartered?
TNF Pharmaceuticals, Inc. is headquartered in United States.
Does TNFA pay a dividend?
TNF Pharmaceuticals, Inc. (TNFA) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did TNFA go public?
TNF Pharmaceuticals, Inc. (TNFA) completed its initial public offering in 2014.